These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29304210)

  • 1. Overview of antifungal dosing in invasive candidiasis.
    Pea F; Lewis RE
    J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i33-i43. PubMed ID: 29304210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
    Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
    Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
    Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
    Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing of antifungal agents in obese people.
    Payne KD; Hall RG
    Expert Rev Anti Infect Ther; 2016; 14(2):257-67. PubMed ID: 26641135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A; Ferriols-Lisart R; Aguilar G; Ezquer-Garín C; Belda FJ; Guglieri-López B
    Int J Antimicrob Agents; 2018 Jan; 51(1):115-121. PubMed ID: 28666752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins].
    Almirante B; Garnacho-Montero J; Maseda E; Candel FJ; Grau S; Guinea J; Moreno I; Muñoz P; Ruiz-Santana S
    Rev Esp Quimioter; 2017 Oct; 30(5):355-367. PubMed ID: 28945064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients.
    Ferrer R; Zaragoza R; Llinares P; Maseda E; Rodríguez A; Quindós G;
    Med Intensiva; 2017; 41(1):3-11. PubMed ID: 27645566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of fluconazole in critically ill patients.
    Sinnollareddy M; Peake SL; Roberts MS; Playford EG; Lipman J; Roberts JA
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1431-40. PubMed ID: 21883033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.
    Miyazaki T; Kohno S
    Expert Rev Anti Infect Ther; 2015; 13(9):1171-83. PubMed ID: 26089168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
    Epico Project Group
    Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
    Bailly S; Bouadma L; Azoulay E; Orgeas MG; Adrie C; Souweine B; Schwebel C; Maubon D; Hamidfar-Roy R; Darmon M; Wolff M; Cornet M; Timsit JF
    Am J Respir Crit Care Med; 2015 May; 191(10):1139-46. PubMed ID: 25780856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.
    Novy E; Roger C; Roberts JA; Cotta MO
    Crit Care; 2023 Nov; 27(1):449. PubMed ID: 37981676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
    Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
    Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
    Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
    Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review.
    Sinnollareddy M; Peake SL; Roberts MS; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):1-10. PubMed ID: 21925845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidemia and invasive candidiasis in adults: A narrative review.
    Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
    Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM; van der Elst KC; Veringa A; Jongedijk EM; Brüggemann RJ; Koster RA; Kampinga GA; Kosterink JG; van der Werf TS; Zijlstra JG; Touw DJ; Alffenaar JWC
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population.
    Scott BL; Hornik CD; Zimmerman K
    Expert Opin Drug Metab Toxicol; 2020 Jul; 16(7):605-616. PubMed ID: 32508205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial.
    Mylonakis E; Zacharioudakis IM; Clancy CJ; Nguyen MH; Pappas PG
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
    Bailly S; Leroy O; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Azoulay E; Timsit JF
    Intensive Care Med; 2015 Nov; 41(11):1931-40. PubMed ID: 26370688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.